BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SSI
3551
DELISTED
Stage Stores Inc
SSI
| $3.91M | ﹤0.01% |
481,212
-2,573
| -0.5% | -$9.97K |
|
3552
China Yuchai International
CYD
$1.78B
| $3.88M | ﹤0.01% |
291,428
-7,263
| -2% | -$97.6K |
|
|
NIHD
3553
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $3.86M | ﹤0.01% |
1,777,621
+1,419
| +0.1% | +$2.75K |
|
3554
iShares High Yield Systematic Bond ETF
HYDB
$1.6B
| $3.82M | ﹤0.01% |
75,281
-8,280
| -10% | -$417K |
|
3555
Bank7 Corp
BSVN
$481M
| $3.81M | ﹤0.01% |
201,157
+1,007
| +0.5% | +$18.8K |
|
|
CYBE
3556
DELISTED
Cyberoptics Corp
CYBE
| $3.8M | ﹤0.01% |
206,850
-537
| -0.3% | -$9.12K |
|
3557
Aspen Aerogels
ASPN
$518M
| $3.8M | ﹤0.01% |
489,353
-3,930
| -0.8% | -$27.1K |
|
|
LEAF
3558
DELISTED
Leaf Group Ltd.
LEAF
| $3.75M | ﹤0.01% |
936,794
+363
| +0% | +$1.34K |
|
|
IBHA
3559
DELISTED
iShares iBonds 2021 Term High Yield and Income ETF
IBHA
| $3.74M | ﹤0.01% |
150,000
-50,000
| -25% | -$1.25M |
|
|
S
3560
PUT
DELISTED
Sprint Corporation
S
| $3.73M | ﹤0.01% |
716,500
-13,500
| -2% | -$79.1K |
|
|
NBLX
3561
DELISTED
Noble Midstream Partners LP
NBLX
| $3.71M | ﹤0.01% |
139,767
+12,703
| +10% | +$300K |
|
|
BMY.RT
3562
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $3.71M | ﹤0.01% |
+1,230,852
| New | +$3.2M |
|
3563
Orion Group Holdings
ORN
$418M
| $3.71M | ﹤0.01% |
713,833
+20,075
| +3% | +$99.6K |
|
3564
PrimeEnergy Resources
PNRG
$298M
| $3.7M | ﹤0.01% |
24,442
-193
| -0.8% | -$28.3K |
|
3565
Corporacion America
CAAP
$4.09B
| $3.68M | ﹤0.01% |
612,907
-168,679
| -22% | -$756K |
|
3566
ACM Research
ACMR
$5.79B
| $3.67M | ﹤0.01% |
596,775
+156,075
| +35% | +$768K |
|
|
KZR
3567
DELISTED
Kezar Life Sciences
KZR
| $3.64M | ﹤0.01% |
90,880
+989
| +1% | +$30.4K |
|
|
LOGC
3568
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $3.64M | ﹤0.01% |
505,280
+38,159
| +8% | +$345K |
|
|
LUNA
3569
DELISTED
Luna Innovations Incorporated
LUNA
| $3.63M | ﹤0.01% |
498,403
-516
| -0.1% | -$3.4K |
|
|
AE
3570
DELISTED
Adams Resources & Energy Inc
AE
| $3.62M | ﹤0.01% |
95,149
-236
| -0.2% | -$7.66K |
|
3571
Harrow
HROW
$1.51B
| $3.62M | ﹤0.01% |
465,054
+54,087
| +13% | +$313K |
|
3572
Inspired Entertainment
INSE
$175M
| $3.61M | ﹤0.01% |
535,234
+1,833
| +0.3% | +$13.1K |
|
|
CYOU
3573
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $3.6M | ﹤0.01% |
368,105
+3,563
| +1% | +$34.3K |
|
|
IMDX
3574
Insight Molecular Diagnostics
IMDX
$156M
| $3.57M | ﹤0.01% |
79,350
-53
| -0.1% | -$1.91K |
|
3575
PUT
Uber
UBER
$153B
| $3.57M | ﹤0.01% |
+120,000
| New | +$3.56M |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.